Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Tolerability of Initiating Aripiprazole Lauroxil in Subjects With Schizophrenia Who Are Inadequately Treated With Paliperidone Palmitate or Risperidone Long Acting Injection

Trial Profile

Safety and Tolerability of Initiating Aripiprazole Lauroxil in Subjects With Schizophrenia Who Are Inadequately Treated With Paliperidone Palmitate or Risperidone Long Acting Injection

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 18 May 2022 Results of post-hoc analysis presented at the 27th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
  • 18 Sep 2017 Primary endpoint has been met. (Change from baseline in Clinical Global Impressions-Severity (CGI-S) scores), according to an Alkermes plc media release
  • 18 Sep 2017 Positive 6-months topline results from this trial were presented at the 30th Annual Psych Congress (Psych Congress), according to an Alkermes plc media release

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top